Roivant Sciences Ltd.
Health
Performance
4.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

Roivant Sciences Ltd. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
Losing steam. Solid pieces remain, but cracks are showing.
28.10.2025
Risk creeping up. Stability not bulletproof anymore.
12.10.2025
Outperforming hard. Momentum locked in.

Roivant Sciences Ltd. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Roivant Sciences Ltd. do? Business model and key facts

Get the full picture of Roivant Sciences Ltd.: what it builds, where it operates, and how it makes money.

Roivant Sciences Ltd. Profile

Sector: Healthcare

Industry: Biotechnology

Employees (FY): 908

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

shop
Company facts
Matthew Gline
CEO
908
Employees worldwide
shop
Performance
110.48%
Last 12 months
127.43%
Last 5 years
shop
Growth
$29,05M
Revenue year
$-356.734.000
Net income
shop
Valuation
$16,20B
Market Cap
-42.56
Price/Earnings Ratio

Stocks related to Roivant Sciences Ltd.

Selected based on industry alignment and relative market positioning.

RPRX
Royalty Pharma plc
39.47
-0.63%
2.6
Sell
Buy
Royalty Pharma plc
INCY
Incyte Corporation
106.52
+1.22%
4.3
Sell
Buy
Incyte Corporation
GMAB
Genmab A/S
34.06
+0.61%
3.8
Sell
Buy
Genmab A/S
MRNA
Moderna, Inc.
41.09
+4.40%
6.4
Sell
Buy
Moderna, Inc.
BBIO
BridgeBio Pharma, Inc.
76.33
+0.09%
5.6
Sell
Buy
BridgeBio Pharma, Inc.

Roivant Sciences Ltd. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.